Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan (Ms Yeh and Dr Lai) (firstname.lastname@example.org); and Hepatitis Research Center, National Taiwan University and Hospital, Taipei, Taiwan (Dr Chen).
To the Editor: Nucleoside analogues are an effective treatment against HBV infection. However, previous studies have yielded inconclusive results regarding a reduction in the risk of HCC recurrence following the use of these treatments due to the small number of patients. Using a nationwide cohort, Dr Wu and colleagues1 reported survival benefits for patients treated with nucleoside analogues. We have 2 comments to make regarding their findings.
Yeh Y, Chen P, Lai M. Antiviral Therapy and Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence. JAMA. 2013;309(8):765-767. doi:10.1001/jama.2013.571